| Followers | 469 |
| Posts | 30247 |
| Boards Moderated | 0 |
| Alias Born | 11/12/2016 |
Friday, October 18, 2024 9:14:42 PM
Dallas, Texas--(Newsfile Corp. - October 18, 2024) - Mangoceuticals, Inc. (NASDAQ: MGRX), a company focused on developing, marketing, and selling men’s health and wellness products via a secure telemedicine platform,, is pleased to announce it will be presenting at the Centurion One Capital 2nd Annual Bahamas Summit, which will be taking place at the exclusive Rosewood Baha Mar Hotel from Tuesday, October 22nd to Wednesday, October 23rd, 2024, in Nassau, Bahamas.
Jacob Cohen, Founder and CEO, is scheduled to present on Wednesday, October 23rd at 11:10 EDT. Jacob will also be fielding investor questions during the summit.
The Centurion One Capital 2nd Annual Bahamas Summit will feature public and private companies across various industries that will be given the opportunity to present to some of the most prominent venture capital, family office, private equity firms, high net worth individuals and institutional investors in the growth space attending from Canada, the United States, and abroad. For registration details, please click here.
Summit Details:
Event: Centurion One Capital 2nd Annual Bahamas Summit
Format: Presentations, Q&A, Panel Discussions and 1 X 1 Investor Meetings
Dates: Tuesday, October 22nd and Wednesday, October 23rd, 2024
Time: 9:00 AM EDT – 4:00 PM EDT
Venue: Rosewood Baha Mar Hotel
About Centurion One Capital
Centurion One Capital (“Centurion One”) is the premier independent Investment Banking firm dedicated to fueling the growth and success of growth companies in North America. With an unwavering commitment to delivering comprehensive financial solutions and strategic guidance, Centurion One is a trusted strategic partner and catalyst to propel issuers to unlock their full potential. Our team comprises seasoned professionals who combine extensive financial expertise with deep knowledge of various sectors. We take a proactive and results-driven approach, working closely with our clients to develop tailored strategies and execute transactions that maximize value and drive long-term success.
Centurion One - Empowering Growth. Driving Innovation. Partnering for Success.
Recent MGRX News
- Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds • GlobeNewswire Inc. • 03/06/2026 09:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2026 09:05:40 PM
- Mangoceuticals’ Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study • GlobeNewswire Inc. • 02/23/2026 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/19/2026 09:05:51 PM
- MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program • GlobeNewswire Inc. • 02/19/2026 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2026 09:30:23 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/29/2026 05:15:19 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/23/2026 10:07:13 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/13/2026 10:30:48 PM
- Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements • GlobeNewswire Inc. • 12/19/2025 03:38:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2025 02:28:40 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/19/2025 02:13:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2025 12:30:48 PM
- Mangoceuticals, Inc. Announces Partnership with The Cube Group to Launch Up To $100 Million Solana-Focused Digital Asset Treasury (DAT) Strategy • GlobeNewswire Inc. • 12/19/2025 12:30:00 PM
- Mangoceuticals, Inc. Announces $2.5 Million Registered Direct and Private Placements Priced at the Market Under Nasdaq Rules • GlobeNewswire Inc. • 12/18/2025 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/10/2025 11:40:28 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/26/2025 09:30:13 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/19/2025 04:46:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 10:17:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 12:00:41 PM
- Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs • GlobeNewswire Inc. • 11/14/2025 12:37:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 12:00:49 PM
- Mangoceuticals Partners with Eli Lilly and Novo Nordisk to Deliver Affordable Access to Zepbound and Wegovy for Obesity Management • GlobeNewswire Inc. • 11/13/2025 12:00:00 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
